Reviv3 Procare Company
RVIV · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | – | $0 | $5,498 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $0 | – | $0 | $0 |
| Gross Profit | $4,635 | – | $4,966 | $5,498 |
| % Margin | – | – | – | 100% |
| R&D Expenses | $0 | – | $0 | $0 |
| G&A Expenses | $160 | – | $392 | $435 |
| SG&A Expenses | $2,920 | – | $3,386 | $3,812 |
| Sales & Mktg Exp. | $2,760 | – | $2,994 | $3,378 |
| Other Operating Expenses | $0 | – | $997 | $1,013 |
| Operating Expenses | $2,920 | – | $4,383 | $4,825 |
| Operating Income | $990 | – | $583 | $673 |
| % Margin | – | – | – | 12.2% |
| Other Income/Exp. Net | $0 | – | $47 | $28 |
| Pre-Tax Income | $0 | – | $630 | $701 |
| Tax Expense | $0 | – | $53 | $67 |
| Net Income | $0 | – | $577 | $634 |
| % Margin | – | – | – | 11.5% |
| EPS | 0 | – | 0.09 | 0.098 |
| % Growth | – | – | -8.4% | – |
| EPS Diluted | 0 | – | 0.07 | 0.059 |
| Weighted Avg Shares Out | 0 | – | 6,517 | 6,450 |
| Weighted Avg Shares Out Dil | 0 | – | 8,202 | 10,771 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | – | $44 | $27 |
| Interest Expense | $0 | – | $1 | -$1 |
| Depreciation & Amortization | $62 | – | $0 | $0 |
| EBITDA | $62 | – | $583 | $673 |
| % Margin | – | – | – | 12.2% |